Proteomic analysis of the chemosensitizing effect of curcumin on CRC cells treated with 5-FU

BACKGROUND: 5-Fluorouracil (5-FU) is one of the most common chemotherapy drugs used to treat colorectal cancer (CRC), which often develops resistance in more than 15% of patients. Curcumin, an active component of Curcuma longa, has been reported to show antitumor activity in CRC and, furthermore, en...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Jingbo, He, Chengyan, Liu, Ning
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9729741/
https://www.ncbi.nlm.nih.gov/pubmed/36507511
http://dx.doi.org/10.3389/fmed.2022.1032256

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9729741/
https://www.ncbi.nlm.nih.gov/pubmed/36507511
http://dx.doi.org/10.3389/fmed.2022.1032256

Ejemplares similares